Sustained viral suppression with once daily dolutegravir-containing regimen in presence of the strong inducer carbamazepine
Sign Up to like & getrecommendations! Published in 2025 at "Antiviral Therapy"
DOI: 10.1177/13596535251335080
Abstract: Dolutegravir 50 mg twice daily (BID) dosing is currently recommended in presence of strong inducers of drug metabolism. However, this dosing has been challenged by studies showing similar rates of viral suppression with dolutegravir once… read more here.
Keywords: presence; strong inducer; viral suppression; presence strong ... See more keywords